Aldeyra Therapeutics, Inc. (ALDX) › Total AssetsAldeyra Therapeutics, Inc. (ALDX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2013: $3.74M2014: $8.79M2015: $28.20M2016: $25.19M2017: $44.17M2018: $95.09M2019: $75.52M2020: $83.35M2021: $233.14M2022: $181.29M2023: $148.33M2024: $104.61M2025: $72.06M$72.06M2013Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$72.06M-31.1%2024$104.61M-29.5%2023$148.33M-18.2%2022$181.29M-22.2%2021$233.14M+179.7%2020$83.35M+10.4%2019$75.52M-20.6%2018$95.09M+115.3%2017$44.17M+75.4%2016$25.19M-10.7%2015$28.20M+221.0%2014$8.79M+134.7%2013$3.74M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share